Published in Ann Plast Surg on August 01, 2016
IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02
Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol (2009) 3.41
Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl (1997) 2.42
Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol (2008) 2.29
Clinical practice. Hidradenitis suppurativa. N Engl J Med (2012) 2.01
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol (2010) 1.70
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol (2007) 1.55
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol (2006) 1.54
The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol (1996) 1.51
A review of wide surgical excision of hidradenitis suppurativa. BMC Dermatol (2012) 1.18
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol (2011) 1.14
Hidradenitis suppurativa. Surg Clin North Am (2002) 1.13
Surgical approach to extensive hidradenitis suppurativa. Dermatol Surg (2011) 1.12
TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol (2011) 1.10
Surgical management of hidradenitis suppurativa. Int J Med Sci (2010) 1.07
Morbidity in patients with hidradenitis suppurativa. Br J Dermatol (2001) 1.06
Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg (2000) 1.05
Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol (2006) 1.04
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol (2011) 1.00
Perianal hidradenitis suppurativa. The Lahey Clinic experience. Dis Colon Rectum (1990) 0.99
A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol (2011) 0.98
Recurrence after surgical treatment of hidradenitis suppurativa. Br Med J (Clin Res Ed) (1987) 0.96
Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol (2009) 0.95
What causes hidradenitis suppurativa? Exp Dermatol (2008) 0.92
Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery (2005) 0.91
Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis (2001) 0.90
Experience with different treatment modules in hidradenitis suppuritiva: a study of 106 cases. Surgeon (2005) 0.89
Surgical treatment of hidradenitis suppurativa: experiences and recommendations. Dermatol Surg (2010) 0.87
Hidradenitis suppurativa complicating naevus comedonicus: the possible influence of mechanical stress on the development of hidradenitis suppurativa. Dermatology (2010) 0.86
Medical treatment of hidradenitis suppurativa. Expert Opin Pharmacother (2004) 0.84
Management of recalcitrant hidradenitis suppurativa with ustekinumab. Acta Derm Venereol (2012) 0.84
Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa. J Eur Acad Dermatol Venereol (2011) 0.84
Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis (1998) 0.83
A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol (2011) 0.83
Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial. Exp Dermatol (2009) 0.82
Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy. J Gastroenterol (2003) 0.82
Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device. Plast Reconstr Surg (2014) 0.82
Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol (2007) 0.81
Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa. Ann Rheum Dis (2012) 0.80
Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol (2007) 0.80
Management of regional hidradenitis suppurativa with vacuum-assisted closure and split thickness skin grafts. Ann Plast Surg (2011) 0.80
Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatolog Treat (2005) 0.80
New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab. Br J Dermatol (2011) 0.77
Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy. J Cutan Med Surg (2013) 0.76
The basic science of wound healing. Plast Reconstr Surg (2006) 3.63
The new reconstructive ladder: modifications to the traditional model. Plast Reconstr Surg (2011) 1.84
Wound healing: an overview. Plast Reconstr Surg (2006) 1.83
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst (2012) 1.78
Mechanisms and clinical applications of the vacuum-assisted closure (VAC) Device: a review. Am J Clin Dermatol (2005) 1.70
Analyzing implant movement with tabbed and nontabbed expanders through the process of two-stage breast reconstruction. Plast Reconstr Surg (2014) 1.49
Current Concepts in Debridement: Science and Strategies. Plast Reconstr Surg (2016) 1.40
The impact of negative-pressure wound therapy with instillation compared with standard negative-pressure wound therapy: a retrospective, historical, cohort, controlled study. Plast Reconstr Surg (2014) 1.33
The mechanisms of action of vacuum assisted closure: more to learn. Surgery (2009) 1.25
Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg (2004) 1.13
Workhorse flaps in chest wall reconstruction: the pectoralis major, latissimus dorsi, and rectus abdominis flaps. Semin Plast Surg (2011) 1.09
Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J Surg Res (2007) 1.09
Does mesh location matter in abdominal wall reconstruction? A systematic review of the literature and a summary of recommendations. Plast Reconstr Surg (2013) 1.06
Use of negative pressure therapy on closed surgical incisions: a case series. Ostomy Wound Manage (2009) 1.04
The role of peripheral nerve surgery in the treatment of chronic pain associated with amputation stumps. Plast Reconstr Surg (2008) 1.02
The importance of limb preservation in the diabetic population. J Diabetes Complications (2011) 1.02
Leg ulcers associated with Klinefelter's syndrome: a case report and review of the literature. Int Wound J (2011) 1.01
SDH-related pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab (2010) 1.00
Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg (2009) 1.00
Wound healing in the upper and lower extremities: a systematic review on the use of acellular dermal matrices. Plast Reconstr Surg (2012) 1.00
Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res (Hoboken) (2010) 0.99
Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds. Ostomy Wound Manage (2006) 0.98
External fixators as an adjunct to wound healing. Foot Ankle Clin (2008) 0.98
Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol (2010) 0.96
Comparison of Outcomes for Normal Saline and an Antiseptic Solution for Negative-Pressure Wound Therapy with Instillation. Plast Reconstr Surg (2015) 0.95
Inpatient management of diabetic foot disorders: a clinical guide. Diabetes Care (2013) 0.95
A review of mechanical adjuncts in wound healing: hydrotherapy, ultrasound, negative pressure therapy, hyperbaric oxygen, and electrostimulation. Ann Plast Surg (2003) 0.92
Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab (2010) 0.92
Débridement of the noninfected wound. J Vasc Surg (2010) 0.91
Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol (2013) 0.91
Special considerations in the management of osteomyelitis defects (diabetes, the ischemic or dysvascular bed, and irradiation). Semin Plast Surg (2009) 0.90
Guidelines regarding negative wound therapy (NPWT) in the diabetic foot. Ostomy Wound Manage (2004) 0.90
Functional reconstruction of the diabetic foot. Semin Plast Surg (2010) 0.89
Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression. Clin Rheumatol (2011) 0.88
Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre. Int Wound J (2011) 0.87
Blood loss estimation during fronto-orbital advancement: implications for blood transfusion practice and hospital length of stay. J Craniofac Surg (2012) 0.87
Immediate, Multistaged Approach to Infected Synthetic Mesh: Outcomes After Abdominal Wall Reconstruction With Porcine Acellular Dermal Matrix. Ann Plast Surg (2015) 0.87
Chronic leg ulceration associated with polycythemia vera responding to ruxolitinib (Jakafi(®)). J Foot Ankle Surg (2013) 0.84
Negative-pressure wound therapy with instillation: international consensus guidelines. Plast Reconstr Surg (2013) 0.83
The use of negative pressure wound therapy for random local flaps at the ankle region. J Foot Ankle Surg (2010) 0.82
Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine. N Engl J Med (2011) 0.81
Foot and ankle reconstruction: pedicled muscle flaps versus free flaps and the role of diabetes. Plast Reconstr Surg (2011) 0.81
Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty. J Pediatr Endocrinol Metab (2014) 0.80
Late complications of chest wall reconstruction: management of painful sternal nonunion. Semin Plast Surg (2011) 0.80
Levamisole-induced occlusive necrotising vasculitis in cocaine abusers: an unusual cause of skin necrosis and neutropenia. Int Wound J (2012) 0.79
Introduction to chest wall reconstruction: anatomy and physiology of the chest and indications for chest wall reconstruction. Semin Plast Surg (2011) 0.79
Lengthening the Achilles tendon for the treatment of diabetic plantar forefoot ulceration. Surg Clin North Am (2003) 0.79
Innovation and management of diabetic foot wounds. Surg Technol Int (2010) 0.79
Amputation in the diabetic to maximize function. Semin Vasc Surg (2012) 0.79
A systematic review of skin substitutes for foot ulcers. Plast Reconstr Surg (2012) 0.79
Muslin-induced intracranial vasculopathic stenosis: a report of two cases. Clin Neurol Neurosurg (2011) 0.78
Single-stage surgical treatment of noninfected diabetic foot ulcers. Plast Reconstr Surg (2002) 0.78
Angiosomes and wound care in the diabetic foot. Foot Ankle Clin (2010) 0.78
Critical elements to building an effective wound care center. J Vasc Surg (2013) 0.78
Outcomes after 294 transtibial amputations with the posterior myocutaneous flap. Int J Low Extrem Wounds (2014) 0.77
Outcomes of microvascular reconstruction of single-vessel lower extremities: limb salvage versus amputation. J Reconstr Microsurg (2009) 0.77
Prevention of Painful Neuroma and Phantom Limb Pain After Transfemoral Amputations Through Concomitant Nerve Coaptation and Collagen Nerve Wrapping. Neurosurgery (2016) 0.76
Negative pressure wound therapy with instillation: past, present, and future. Surg Technol Int (2015) 0.76
A thirteen year old female with primary T-cell rich B-cell lymphoma of bone masquerading as chronic recurrent multifocal osteomyelitis. Pediatr Rep (2009) 0.76
Complex perineal and groin wound reconstruction using the extended dissection technique of the gracilis flap. Plast Reconstr Surg (2008) 0.76
External fixation: indications in lower extremity reconstruction and limb salvage. Plast Reconstr Surg (2009) 0.76
A brief history of wound care. Plast Reconstr Surg (2006) 0.76
The U-Shaped Tensor Fasciae Latae Musculocutaneous Flap for Coverage of Trochanteric Defects: Simplified Design to Minimize Donor-Site Morbidity. Plast Reconstr Surg (2015) 0.76
Debridement of the noninfected wound. J Am Podiatr Med Assoc (2010) 0.75
What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? Plast Reconstr Surg (2016) 0.75
Abstract 115: Combined Free Tissue Transfer For The Management Of Composite Achilles Defects: Functional Outcomes And Patient Satisfaction Following Vascularized Reconstruction With A Neo-tendon Construct. Plast Reconstr Surg (2014) 0.75
Abdominal wall reconstruction with implantable meshes. J Long Term Eff Med Implants (2011) 0.75
Late Hematoma Following Central Venous Port Removal. Plast Reconstr Surg (2016) 0.75
Building a Multidisciplinary Hospital-Based Wound Care Center: Nuts and Bolts. Plast Reconstr Surg (2016) 0.75
Ertl below-knee amputation using a vascularized fibular strut in a nontrauma elderly population: a case series. Ann Plast Surg (2014) 0.75
Combat Wound Initiative program. Mil Med (2010) 0.75
Applications of fat grafting in facial aesthetic skeletal surgery. Aesthet Surg J (2014) 0.75
Factors associated with failed hardware salvage in high-risk patients after microsurgical lower extremity reconstruction. Ann Plast Surg (2012) 0.75
Role of the podiatrist in diabetic limb salvage. J Vasc Surg (2012) 0.75
The Rise of Evidence in Microsurgical Practice. Plast Reconstr Surg (2020) 0.75
Systematic review of patient-centered outcomes following lower extremity flap reconstruction in comorbid patients. J Reconstr Microsurg (2013) 0.75
Free Tissue Transfer in Patients with Sickle Cell Trait: Not Just a Trait. Plast Reconstr Surg (2015) 0.75
The Effect of Positive Post-Debridement Cultures on Local Muscle Flap Reconstruction of the Lower Extremity. Plast Reconstr Surg (2015) 0.75
Home Improvement in Maggot Therapy: Designing a Simple, Cost-Effective, Closed-System Habitat to Facilitate Biodébridement of Complex Distal Lower Extremity Wounds. Plast Reconstr Surg (2015) 0.75
Evidence to support controversy in microsurgery. Plast Reconstr Surg (2015) 0.75
Below-knee amputation with a vascularized fibular graft and headless compression screw. Plast Reconstr Surg (2013) 0.75
Reply: Comparison of Outcomes for Normal Saline and an Antiseptic Solution for Negative-Pressure Wound Therapy with Instillation. Plast Reconstr Surg (2016) 0.75
Chest wall reconstruction. Semin Plast Surg (2011) 0.75
Multidisciplinary approach to soft-tissue reconstruction of the diabetic Charcot foot. Plast Reconstr Surg (2015) 0.75
Late Hematoma following Central Venous Port Removal. Plast Reconstr Surg (2017) 0.75
Combined Achilles tendon and soft tissue defects: functional outcomes of free tissue transfers and tendon vascularization. Ann Plast Surg (2015) 0.75